PCL

본문 바로가기

팝업레이어 알림

팝업레이어 알림이 없습니다.
pcl

PRODUCT
Multi-immune source technology-based platform capable of diagnosing various diseases
POCT platform​
PCLOKⅡ
POCT platform
6 tests within 30 min in the field​
Portable Immunoassay system​
Suitable for SMH, Health center, etc.​
Mutiplex Immunoassay for various specimens​
Platform for ABC (FluA/B, and COVID-19)​
Blood screening​ Tumor marker​ Respiratory​ Antibody titer for PET​
Model​ Hi06 Hi07 Ci02 Ri01 Ri02 Vi01 Vi02
Spot​ Image
Test​ Marker Anti – HIV
Anti – HCV
Anti - Syphilis
HBsAg
HIV p24
CA 19-9
AFP
CEA
PSA
CA 125
Flu A
Flu B
RSV
Flu A
Flu B
COVID-19
CDV
CPV
CPIV
CAV-2
CCoV
FCV
FPV
FVR
FIP
Chlamydia
Capacity​ 6 ~ 18 T/hr
Overview​
Difficulties in operating the system at developing countries​
·Insufficient technical ability​
·Instable electricity supply​
·Small sample scale​
Developed as a solution for given circumstances in developing countries.​
·Smaller equipment​
·Smaller test unit scale​
·Reduced the difficulty of use​
Antigen & Antibody Diagnostic Kit
PCLOK II Anti-HIV/HCV/Syphilis product design​
Classification​
HIVㆍHBVㆍHCVㆍHTLV Immunoassay reagent​
K05010.01[4]​
Product name​
PCLOK II Anti-HIV/HCV/Syphilis
Model name​
Hi06
Manufacturer​
PCL Inc.​
Intended Use​
Qualitative fluorescence immunoassay
for the simultaneous detection
of antibodies to HIV1/2, HCV,
and Syphilis in Human serum or plasma​
PCLOK II HBsAg/HIV p24 product design
Classification​
HIVㆍHBVㆍHCVㆍHTLV Immunoassay reagent​
K05010.01[4]​
Product name​
PCLOK II HBsAg/HIV p24
Model name​
Hi07
Manufacturer​
PCL Inc.​
Intended Use​
Qualitative fluorescence immunoassay
for the simultaneous detection
of HBsAg and/or HIV p24 antigen
in Human serum or plasma​